Dizhe Pharmaceutical announced in the morning that on August 27, the company re-submitted an application to issue H shares and list them on the main board of the Hong Kong Stock Exchange, and published the application materials for this issuance and listing on the Hong Kong Stock Exchange website on the same day.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.